Contemporary trial data in high risk patient groups do not show convincing evidence that intensive lipid lowering causes major neurocognitive harm, dementia, or a clear excess of haemorrhagic stroke in selected patients, even at very low achieved LDL-C levels [9], [10], [11], [12], [13], [14], [15], [16]
With a starting weight of 250 pounds, Ive updated a couple of times along the way, but nearly two years in, I thought it was time to reflect againon the challenges, surprises, and victories so far
However, the AngII/AT1 receptor system influences multiple functions beyond blood pressure, including body water balance, control of vasopressin and oxytocin release and sexual reproduction and behavior, thus undesirable drug-induced effects are possible
Liraglutide, marketed under the brand names Victoza for diabetes management and Saxenda for weight management, is a versatile GLP-1 receptor agonist with a distinct focus on weight loss
the risk of methotrexate-induced liver injury is primarily acute in nature